MedPath

辽宁海思科制药有限公司

Ownership
-
Established
2005-05-19
Employees
-
Market Cap
-
Website
http://www.haisco.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Compound Amino Acid Injection(20AA)

Product Name
复方氨基酸注射液(20AA)
Approval Number
国药准字H20183437
Approval Date
Sep 20, 2023
NMPA

Nalmefene Hydrochloride Injection

Product Name
抒纳
Approval Number
国药准字H20080652
Approval Date
Jul 4, 2023
NMPA

Palonosetron Hydrochloride Injection

Product Name
盐酸帕洛诺司琼注射液
Approval Number
国药准字H20183343
Approval Date
May 29, 2023
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字H20133233
Approval Date
May 29, 2023
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字H20133234
Approval Date
May 29, 2023
NMPA

Medium and Long Chain Fat Emulsion,Amino Acids(16) and Glucose(16%) Injection

Product Name
中长链脂肪乳/氨基酸(16)/葡萄糖(16%)注射液
Approval Number
国药准字H20183337
Approval Date
May 29, 2023
NMPA

Fat Emulsion,Amino Acids(17) and Glucose(11%) Injection

Product Name
脂肪乳氨基酸(17)葡萄糖(11%)注射液
Approval Number
国药准字H20217055
Approval Date
Feb 22, 2023
NMPA

Fat Emulsion, Amino Acids(17)and Glucose(11%)Injection

Product Name
脂肪乳氨基酸(17)葡萄糖(11%)注射液
Approval Number
国药准字H20183051
Approval Date
Feb 14, 2023
NMPA

Compound Vitamines for Injection

Product Name
注射用复方维生素(3)
Approval Number
国药准字H20130041
Approval Date
Feb 14, 2023
NMPA

Cefmenoxime Hydrochloride

Product Name
盐酸头孢甲肟
Approval Number
国药准字H20123248
Approval Date
Jul 25, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.